C12N2770/36122

MODULAR VIRAL GENOMES AND METHODS OF PRODUCING THE SAME
20240067934 · 2024-02-29 ·

Disclosed herein are modular viral genomes comprising multiple individual DNA fragments, where each DNA fragment comprises a nucleic acid and at least one viral adaptor region at a terminal end of the nucleic acid. Individual DNA fragments may be assembled based on the homologous viral adaptor regions of each DNA fragment. Also disclosed herein are methods of producing a modular viral genome.

Alphavirus NSP Mutants as Vaccines
20190359656 · 2019-11-28 ·

The present invention generally relates to polypeptides, polynucleotides, expression vectors, infectious clones, virus particles and immunogenic compositions of recombinant alphaviruses which can be used as vaccines. The present disclosure also relates to methods for eliciting an immune response against alphavirus infection using the immunogenic composition comprising the alphavirus mutants described herein.

GENOME EDITING REAGENTS AND THEIR USE

The application discloses multimeric assemblies packaging one or more active component and their use to carry out nucleic acid regulation or gene editing.

GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA
20190338252 · 2019-11-07 ·

The disclosure provides methods and compositions useful for obtaining induced stem cells, methods of making and use thereof.

CIS-REPLICON CONSTRUCT

Provided is a new-type cis-replicon construct for efficiently expressing a target protein, which comprises an RNA polymerase coding unit and a target protein coding unit. The replicon construct can drive the replication of the target protein coding unit and reduce or avoid the replication and expression of the RNA polymerase, thereby effectively improving the expression of the target protein and reducing the expression of the non-target protein.

CORONAVIRUS VACCINE COMPOSITIONS AND METHODS

Provided herein are nucleic acid molecules encoding viral replication proteins and antigenic coronavirus proteins or fragments thereof. Also provided herein are compositions that include nucleic acid molecules encoding viral replication and antigenic proteins, and lipids. Nucleic acid molecules provided herein are useful for inducing immune responses.

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES

Provided herein are nucleic acid molecules encoding viral replication proteins and antigenic proteins or fragments thereof. Also provided herein are compositions that include nucleic acid molecules encoding viral replication and antigenic proteins, and lipids. Nucleic acid molecules provided herein are useful for inducing immune responses.

Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
10464986 · 2019-11-05 · ·

The present invention provides a virus like particle comprising a virus structural protein and an antigen derived from PD-1 or a ligand of PD-1, and a composition or kit comprising thereof, its use in immune response etc.

Zika RNA vaccines

Aspects of the disclosure describe compositions that comprise RNA polynucleotides having an open reading frame encoding one or more Zika virus antigens. Methods for preparing and using the compositions are also described.

TARGETED GENE DELIVERY FOR DENDRITIC CELL VACCINATION
20190316153 · 2019-10-17 ·

Methods and compositions are provided for delivery of a polynucleotide encoding a gene of interest, typically an antigen, to a dendritic cell (DC). The virus envelope comprises a DC-SIGN specific targeting molecule. The methods and related compositions can be used to treat patients suffering from a wide range of conditions, including infection, such as HIV/AIDS, and various types of cancers.